388 related articles for article (PubMed ID: 29062978)
21. [Neurodevelopmental disorders and epilepsy].
Tuchman RF; Moshe SL; Rapin I
Rev Neurol; 2005 Jan; 40 Suppl 1():S3-10. PubMed ID: 15736089
[TBL] [Abstract][Full Text] [Related]
22. ARX polyalanine expansion mutations lead to migration impediment in the rostral cortex coupled with a developmental deficit of calbindin-positive cortical GABAergic interneurons.
Lee K; Ireland K; Bleeze M; Shoubridge C
Neuroscience; 2017 Aug; 357():220-231. PubMed ID: 28627419
[TBL] [Abstract][Full Text] [Related]
23. Epileptic Encephalopathies-Clinical Syndromes and Pathophysiological Concepts.
von Deimling M; Helbig I; Marsh ED
Curr Neurol Neurosci Rep; 2017 Feb; 17(2):10. PubMed ID: 28229394
[TBL] [Abstract][Full Text] [Related]
24. Mutations in ARX Result in Several Defects Involving GABAergic Neurons.
Friocourt G; Parnavelas JG
Front Cell Neurosci; 2010; 4():4. PubMed ID: 20300201
[TBL] [Abstract][Full Text] [Related]
25. Neuroanatomical distribution of ARX in brain and its localisation in GABAergic neurons.
Poirier K; Van Esch H; Friocourt G; Saillour Y; Bahi N; Backer S; Souil E; Castelnau-Ptakhine L; Beldjord C; Francis F; Bienvenu T; Chelly J
Brain Res Mol Brain Res; 2004 Mar; 122(1):35-46. PubMed ID: 14992814
[TBL] [Abstract][Full Text] [Related]
26. Autism spectrum disorder and epileptic encephalopathy: common causes, many questions.
Srivastava S; Sahin M
J Neurodev Disord; 2017; 9():23. PubMed ID: 28649286
[TBL] [Abstract][Full Text] [Related]
27. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.
Wolff M; Johannesen KM; Hedrich UBS; Masnada S; Rubboli G; Gardella E; Lesca G; Ville D; Milh M; Villard L; Afenjar A; Chantot-Bastaraud S; Mignot C; Lardennois C; Nava C; Schwarz N; Gérard M; Perrin L; Doummar D; Auvin S; Miranda MJ; Hempel M; Brilstra E; Knoers N; Verbeek N; van Kempen M; Braun KP; Mancini G; Biskup S; Hörtnagel K; Döcker M; Bast T; Loddenkemper T; Wong-Kisiel L; Baumeister FM; Fazeli W; Striano P; Dilena R; Fontana E; Zara F; Kurlemann G; Klepper J; Thoene JG; Arndt DH; Deconinck N; Schmitt-Mechelke T; Maier O; Muhle H; Wical B; Finetti C; Brückner R; Pietz J; Golla G; Jillella D; Linnet KM; Charles P; Moog U; Õiglane-Shlik E; Mantovani JF; Park K; Deprez M; Lederer D; Mary S; Scalais E; Selim L; Van Coster R; Lagae L; Nikanorova M; Hjalgrim H; Korenke GC; Trivisano M; Specchio N; Ceulemans B; Dorn T; Helbig KL; Hardies K; Stamberger H; de Jonghe P; Weckhuysen S; Lemke JR; Krägeloh-Mann I; Helbig I; Kluger G; Lerche H; Møller RS
Brain; 2017 May; 140(5):1316-1336. PubMed ID: 28379373
[TBL] [Abstract][Full Text] [Related]
28. Lissencephaly, abnormal genitalia and refractory epilepsy: case report of XLAG syndrome.
Spinosa MJ; Liberalesso PB; Vieira SC; Olmos AS; Löhr A
Arq Neuropsiquiatr; 2006 Dec; 64(4):1023-6. PubMed ID: 17221017
[TBL] [Abstract][Full Text] [Related]
29. Status dystonicus due to missense variant in ARX: Diagnosis and management.
Gorman KM; Cary H; Gaffney L; Forman E; Waldron D; Al-Delami F; Lynch BJ; King MD; Allen NM
Eur J Paediatr Neurol; 2018 Sep; 22(5):862-865. PubMed ID: 29778428
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory or excitatory? Optogenetic interrogation of the functional roles of GABAergic interneurons in epileptogenesis.
Ye H; Kaszuba S
J Biomed Sci; 2017 Dec; 24(1):93. PubMed ID: 29202749
[TBL] [Abstract][Full Text] [Related]
31. Current understanding and neurobiology of epileptic encephalopathies.
Auvin S; Cilio MR; Vezzani A
Neurobiol Dis; 2016 Aug; 92(Pt A):72-89. PubMed ID: 26992889
[TBL] [Abstract][Full Text] [Related]
32. A case of severe progressive early-onset epileptic encephalopathy: unique GABAergic interneuron distribution and imaging.
Inoue T; Kawawaki H; Kuki I; Nabatame S; Tomonoh Y; Sukigara S; Horino A; Nukui M; Okazaki S; Tomiwa K; Kimura-Ohba S; Inoue T; Hirose S; Shiomi M; Itoh M
J Neurol Sci; 2013 Apr; 327(1-2):65-72. PubMed ID: 23422026
[TBL] [Abstract][Full Text] [Related]
33. GABAergic circuit dysfunctions in neurodevelopmental disorders.
Chattopadhyaya B; Cristo GD
Front Psychiatry; 2012; 3():51. PubMed ID: 22666213
[TBL] [Abstract][Full Text] [Related]
34. [Infantile epileptic encephalopathies: what matters is genetics].
Garcia-Penas JJ; Jimenez-Legido M
Rev Neurol; 2017 May; 64(s03):S65-S69. PubMed ID: 28524223
[TBL] [Abstract][Full Text] [Related]
35. Postnatal
Joseph DJ; Von Deimling M; Hasegawa Y; Cristancho AG; Ahrens-Nicklas RC; Rogers SL; Risbud R; McCoy AJ; Marsh ED
iScience; 2021 Jan; 24(1):101999. PubMed ID: 33490907
[TBL] [Abstract][Full Text] [Related]
36. Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives.
Deidda G; Bozarth IF; Cancedda L
Front Cell Neurosci; 2014; 8():119. PubMed ID: 24904277
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic Approach to Genetic Causes of Early-Onset Epileptic Encephalopathy.
Gürsoy S; Erçal D
J Child Neurol; 2016 Mar; 31(4):523-32. PubMed ID: 26271793
[TBL] [Abstract][Full Text] [Related]
38. Development of cortical GABAergic circuits and its implications for neurodevelopmental disorders.
Di Cristo G
Clin Genet; 2007 Jul; 72(1):1-8. PubMed ID: 17594392
[TBL] [Abstract][Full Text] [Related]
39. Identification of Arx targets unveils new candidates for controlling cortical interneuron migration and differentiation.
Friocourt G; Parnavelas JG
Front Cell Neurosci; 2011; 5():28. PubMed ID: 22355284
[TBL] [Abstract][Full Text] [Related]
40. The promise of an interneuron-based cell therapy for epilepsy.
Sebe JY; Baraban SC
Dev Neurobiol; 2011 Jan; 71(1):107-17. PubMed ID: 21154914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
